Results 1 to 10 of about 95,293 (212)

The Outcomes of Myeloid Sarcoma in 64 Pediatric Patients and the Impact of Allogeneic Hematopoietic Stem Cell Transplantation on Treatment Results [PDF]

Children
Background: Myeloid sarcoma (MS) is a malignant extramedullary tumor that occurs in patients with acute myeloid leukemia (AML), myelodysplastic syndrome (MDS), or chronic myeloid leukemia (CML).
Magdalena Samborska, Jolanta Skalska-Sadowska, Jacek Wachowiak, Małgorzata Czogała, Walentyna Balwierz, Szymon Skoczeń, Natalia Bartoszewicz, Jan Styczyński, Tomasz Ociepa, Tomasz Urasiński, Grażyna Wróbel, Krzysztof Kałwak, Katarzyna Muszyńska-Rosłan, Anna Szmydki-Baran, Iwona Malinowska, Paweł Łaguna, Agnieszka Mizia-Malarz, Renata Tomaszewska, Tomasz Szczepański, Agnieszka Chodała-Grzywacz, Grażyna Karolczyk, Lucyna Maciejka-Kembłowska, Marta Kozłowska, Ninela Irga-Jaworska, Katarzyna Mycko, Wanda Badowska, Katarzyna Bobeff, Wojciech Młynarski, Radosław Chaber, Joanna Zawitkowska, Katarzyna Drabko, Katarzyna Derwich   +31 more
doaj   +2 more sources

Longitudinal assessment of oral intake adequacy and nutrition-impacted symptoms in patients undergoing allogeneic hematopoietic stem cell transplantation [PDF]

Frontiers in Nutrition
AimsThis study aims to longitudinally assess the adequacy of oral intake and burden of nutrition-impacted symptoms (NIS) and identify modifiable factors associated with oral intake adequacy in allogeneic hematopoietic stem cell transplantation patients ...
Liyuan Qin, Rui Li, Jiaqi Wu, Yang He
doaj   +2 more sources

Nonmyeloablative Allogeneic Hematopoietic Stem Cell Transplantation [PDF]

Journal of Hematotherapy & Stem Cell Research, 2002
Allogeneic hematopoietic stem cell transplantation (HSCT) is the most effective treatment for selected hematological malignancies. Its curative potential is largely mediated by an immune-mediated destruction of malignant cells by donor lymphocytes termed graft-versus-leukemia (GVL) effect.
Baron, Frédéric, Beguin, Yves
openaire   +3 more sources

Allogeneic Hematopoietic Stem Cell Transplantation [PDF]

Archives of Internal Medicine, 2002
Acute complications such as veno-occlusive disease of the liver, acute and chronic graft-vs-host disease (GVHD), and infectious conditions remain major obstacles for the success of allogeneic hematopoietic stem cell transplantation (HSCT). Progress in allogeneic HSCT depends on several factors, including the adequate prevention and management of ...
Imad A, Tabbara, Kathy, Zimmerman, Connie, Morgan, Zeina, Nahleh   +3 more
openaire   +2 more sources

Immune Reconstitution in the Aging Host: Opportunities for Mechanism-Based Therapy in Allogeneic Hematopoietic Cell Transplantation

Frontiers in Immunology, 2021
Older patients with hematologic malignancies are increasingly considered for allogeneic hematopoietic cell transplantation with encouraging outcomes.
Richard J. Lin, Richard J. Lin, Harold K. Elias, Harold K. Elias, Marcel R. M. van den Brink, Marcel R. M. van den Brink   +5 more
doaj   +1 more source

Hospital and outpatient models for Hematopoietic Stem Cell Transplantation: A systematic review of comparative studies for health outcomes, experience of care and costs.

PLoS ONE, 2021
The number of Hematopoietic Stem Cell Transplantations has risen in the past 20 years. The practice of outpatient Hematopoietic Stem Cell Transplantation programs is increasing in an attempt to improve the quality of patient care and reduce the demand ...
Marino J González, Elena Urizar, Maider Urtaran-Laresgoiti, Roberto Nuño-Solinís, Esther Lázaro-Pérez, Lourdes Vázquez, Maria Jesús Pascual-Cascón, Carlos Solano, Mi Kwon, Cristina Gallego, Francesc Fernández-Avilés   +10 more
doaj   +1 more source

Donor-Derived CD7 CAR-T Therapy Followed by Allogeneic Hematopoietic Stem Cell Transplantation for Acute T-Lymphocytic Leukemia Associated With Hepatitis B: A Case Report

Frontiers in Immunology, 2022
The use of chimeric antigen receptor T cells (CAR-Ts) is effective in the treatment of hematological malignancies. It has been reported that HBV is reactivated after CAR-T immunotherapy for refractory/relapsed hematological malignant B-cell tumors ...
Zhihui Li, Fanqiao Meng, Jing Li, Tong Wu   +3 more
doaj   +1 more source

Quality of Life and psychopathology in adults who underwent Hematopoietic Stem Cell Transplantation (HSCT) in childhood: a qualitative and quantitative analysis. [PDF]

, 2017
Background: Patients who undergo pediatric Hematopoietic Stem Cell Transplantation (HSCT) may experience long-term psychological sequelae and poor Quality of Life (QoL) in adulthood. This study aimed to investigate subjective illness experience, QoL, and
Basso, G., Boscolo, Valentina, Calore, E., Cattelan, C., Di Florio, N., Mainardi, C., Marzollo, A., Messina, C., Pillon, M., Porreca, A., Sinatora, F., Traverso, A., Tremolada, M., Zanato, S.   +13 more
core   +2 more sources

Allogeneic hematopoietic stem-cell transplantation for myelofibrosis [PDF]

Therapeutic Advances in Hematology, 2020
Myelofibrosis is one of the Philadelphia chromosome (Ph)-negative myeloproliferative neoplasms with heterogeneous clinical course. Though many treatment options, including Janus kinase (JAK) inhibitors, have provided clinical benefits and improved survival, allogeneic hematopoietic stem-cell transplantation (AHSCT) remains the only potentially ...
Lining Zhang, Fan Yang, Sizhou Feng
openaire   +3 more sources

Respiratory Virus Infections in Hematopoietic Cell Transplant Recipients

Frontiers in Microbiology, 2019
Highly immunocompromised pediatric and adult hematopoietic cell transplant (HCT) recipients frequently experience respiratory infections caused by viruses that are less virulent in immunocompetent individuals. Most of these infections, with the exception
Cécile Pochon, Sebastian Voigt, Sebastian Voigt   +2 more
doaj   +1 more source